Lou G - Search Results

1

Establishment and clinical application of a prognostic index for inflammatory status in triple-negative breast cancer patients undergoing neoadjuvant therapy using machine learning.

Sun H, Liang J, Xue S, Zhang X, Ding M, Zhu J, Nanding A, Liu T, Lou G, Gao Y, Li Y, Zhong L. Sun H, et al. Among authors: lou g. BMC Cancer. 2024 Dec 20;24(1):1559. doi: 10.1186/s12885-024-13354-8. BMC Cancer. 2024. PMID: 39707255 Free PMC article.

2

A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.

Zhong L, Lou G, Zhou X, Qin Y, Liu L, Jiang W. Zhong L, et al. Among authors: lou g. Oncotarget. 2017 Jul 1;8(40):67861-67870. doi: 10.18632/oncotarget.18919. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978079 Free PMC article.

3

Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models.

Zheng H, Wu L, Chen J, Na N, Lou G. Zheng H, et al. Among authors: lou g. Breast Cancer. 2024 May;31(3):371-381. doi: 10.1007/s12282-024-01543-z. Epub 2024 Jan 30. Breast Cancer. 2024. PMID: 38289410

4

A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis.

Liu Y, Wang W, Yin R, Zhang Y, Zhang Y, Zhang K, Pan H, Wang K, Lou G, Li G, Zhang R, Li K, Rao J, Zhang B, Wang Y, Wang Q, Gao Y, Li H. Liu Y, et al. Among authors: lou g. BMC Med. 2023 Sep 29;21(1):376. doi: 10.1186/s12916-023-03046-8. BMC Med. 2023. PMID: 37775744 Free PMC article. Clinical Trial.

5

DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.

Cheng HY, Gao Y, Lou G. Cheng HY, et al. Among authors: lou g. Eur J Med Res. 2010 Jan 29;15(1):20-4. doi: 10.1186/2047-783x-15-1-20. Eur J Med Res. 2010. PMID: 20159667 Free PMC article.

6

Clinical and prognostic significance of FBXL6 expression in ovarian cancer.

Tao D, Lou S, Huang W, Sun K, Li J, Wang Z, Pi Y, Zhao Y, Wen J, Xie Q, Meng F, Lou G. Tao D, et al. Among authors: lou g. Gene. 2025 Jan 15;933:148978. doi: 10.1016/j.gene.2024.148978. Epub 2024 Oct 3. Gene. 2025. PMID: 39368786 Free article.

7

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

Yin M, Lou C, Zhang W, Meng F, Zhang H, Ning X, Zhou R, Dong X, Lou G. Yin M, et al. Among authors: lou c, lou g. Int J Gynecol Cancer. 2012 Jan;22(1):54-62. doi: 10.1097/IGC.0b013e318234f9ac. Int J Gynecol Cancer. 2012. PMID: 22193644

8

The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.

Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, Hou Y, Li X, Meng F, Chen X. Yin M, et al. Among authors: lou g. Int J Gynecol Cancer. 2011 Jan;21(1):92-9. doi: 10.1111/IGC.0b013e3181fe8b6e. Int J Gynecol Cancer. 2011. PMID: 21330834

9

Integrative analyses of genes associated with oxidative stress and cellular senescence in triple-negative breast cancer.

Wu L, Zheng H, Guo X, Li N, Qin L, Li X, Lou G. Wu L, et al. Among authors: lou g. Heliyon. 2024 Jul 16;10(14):e34524. doi: 10.1016/j.heliyon.2024.e34524. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39130410 Free PMC article.

10

Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.

Meng F, Tan S, Liu T, Song H, Lou G. Meng F, et al. Among authors: lou g. Tumour Biol. 2016 Apr;37(4):4849-55. doi: 10.1007/s13277-015-4319-9. Epub 2015 Nov 2. Tumour Biol. 2016. PMID: 26526574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters